Faron Pharmaceuticals Oy (FARN) — Strategic Asset Allocation Index
Faron Pharmaceuticals Oy (FARN) has a Strategic Asset Allocation Index of 7.1% as of December 2021. Strategic assets (PP&E of GBX207.00K plus long-term investments of GBX-) total GBX207.00K, measured against net assets of GBX2.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Faron Pharmaceuticals Oy Strategic Asset Allocation Index (2015–2021)
This chart shows how Faron Pharmaceuticals Oy's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2021. As of December 2021, the index stands at 7.1%, representing strategic assets of GBX207.00K against net assets of GBX2.92 Million GBX. Explore Faron Pharmaceuticals Oy (FARN) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Faron Pharmaceuticals Oy (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Faron Pharmaceuticals Oy from 2015 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Faron Pharmaceuticals Oy worth.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 7.1% | GBX207.00K | GBX207.00K | GBX- | GBX2.92 Million | ▼ -17.7 pp |
| 2019 | 24.8% | GBX399.00K | GBX399.00K | GBX- | GBX1.61 Million | ▲ +20.2 pp |
| 2018 | 4.6% | GBX17.00K | GBX17.00K | GBX- | GBX369.00K | ▲ +4.1 pp |
| 2017 | 0.5% | GBX22.00K | GBX22.00K | GBX- | GBX4.74 Million | ▲ +0.3 pp |
| 2016 | 0.2% | GBX21.00K | GBX21.00K | GBX- | GBX10.88 Million | ▼ -0.1 pp |
| 2015 | 0.3% | GBX28.00K | GBX28.00K | GBX- | GBX11.18 Million | — |